New York, NY -- (SBWIRE) -- 12/17/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Chimera Investment Corporation (NYSE:CIM), Coronado Biosciences Inc (NASDAQ:CNDO), FreeSeas Inc (NASDAQ:FREE), Geron Corporation (NASDAQ:GERN)
Chimera Investment Corporation (NYSE:CIM) the stock opened the session at $3.06 but then moved to $3.03. At that price, the stock showed a negative performance of -0.33%. Chimera Investment Corporation is a specialty finance company that invests, either directly or indirectly through its subsidiaries, in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities and various other asset classes.
Will CIM Get Buyers Even After The Recent Rally? Find Out Here
Coronado Biosciences Inc (NASDAQ:CNDO) opened the session at $2.11 and closed the session at $2.17. Traded with volume of 3.29 million shares in the prior session and the average volume of the stock remained 2.19 million shares. Coronado Biosciences, Inc. is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company’s two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases,
Is CNDO a Solid Investment at These Levels? Read This Report For Details
FreeSeas Inc (NASDAQ:FREE) opened the session at $1.32 and closed the session at $1.20. The beta of the stock remained 3.47. FreeSeas Inc. (FreeSeas) is a parent holding company of its ship-owning companies. The Company’s fleet consists of six Handysize vessels and one Handymax vessel that carry a variety of drybulk commodities, including iron ore, grain and coal, which are referred to as bulks, as well as bauxite, phosphate, fertilizers, steel products, cement, sugar and rice, or minor bulks.
Is FREE a Solid Investment at These Levels? Read This Report For Details
Geron Corporation (NASDAQ:GERN) traded with volume of 3.24 million shares in the prior session and the average volume of the stock remained 8.12 million shares. The beta of the stock remained 1.24. Geron Corporation (Geron) is a clinical-stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Telomerase is an enzyme that enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a specific inhibitor of telomerase.
Is GERN a Solid Investment at These Levels? Read This Report For Details
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)